More: American Academy of Pain Medicine (AAPM) 24th Annual Meeting

Highlights of the 24th Annual Meeting of the American Academy of Pain Medicine CME/CE

February 12 - 16, 2008, Orlando, Florida

Author Information and Disclosures

This activity is not sanctioned by, nor a part of, the American Academy of Pain Medicine.

Release Date: March 31, 2008; Valid for credit through March 31, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians;
Nurses - 1.0 nursing contact hours (1.0 contact hours are in the area of pharmacology);
Pharmacists - 1.0 ACPE continuing education credits for pharmacists (0.1 CEUs)

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Academy of Pain Medicine. These materials and the related activity are not sanctioned by the American Academy of Pain Medicine or the commercial supporter of the conference and do not constitute an official part of that conference.

Copyright © 2008 Medscape.
PriCara, Division of Ortho-McNeil-Janssen Pharmaceuticals Inc
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Examine the role of pain policy on opioid prescribing habits.
  2. Discuss the impact of drug diversion in the United States.
  3. Review the latest data on opioid use and hyperalgesia.
Authors and Disclosures

Laura A. Stokowski, RN, MS
Disclosure: Laura A. Stokowski, RN, MS, has disclosed that she has served as a consultant for Draeger Medical.


Eugene R. Viscusi, MD
Disclosure: Eugene R. Viscusi, MD, has disclosed that he has served as an advisor or consultant to Ortho-McNeil-Janssen Pharmaceuticals.


Darlene Field, PhD
Disclosure: Darlene Field, PhD, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

 
This Activity is sponsored by Medscape Continuing Education Provider Unit.

Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs; 1.0 contact hours are in the area of pharmacology.

Provider Number: 6FDKKC-PRV-05

Contact This Provider

 
ACPE logoMedscape is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Medscape designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) (Universal Program Number 461-000-08-010-H01-P).

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.